These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9729735)

  • 1. Antibody engineering.
    Dall'Acqua W; Carter P
    Curr Opin Struct Biol; 1998 Aug; 8(4):443-50. PubMed ID: 9729735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody evolution beyond Nature.
    Borrebaeck CA; Ohlin M
    Nat Biotechnol; 2002 Dec; 20(12):1189-90. PubMed ID: 12454662
    [No Abstract]   [Full Text] [Related]  

  • 3. Construction of a semisynthetic antibody library using trinucleotide oligos.
    Braunagel M; Little M
    Nucleic Acids Res; 1997 Nov; 25(22):4690-1. PubMed ID: 9358184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity maturation of phage display antibody populations using ribosome display.
    Groves M; Lane S; Douthwaite J; Lowne D; Rees DG; Edwards B; Jackson RH
    J Immunol Methods; 2006 Jun; 313(1-2):129-39. PubMed ID: 16730741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of synthetic antibody libraries.
    Benhar I
    Expert Opin Biol Ther; 2007 May; 7(5):763-79. PubMed ID: 17477812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage display of combinatorial antibody libraries.
    Rader C; Barbas CF
    Curr Opin Biotechnol; 1997 Aug; 8(4):503-8. PubMed ID: 9265732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An scFv phage clone that binds to human beta2-microglobulin.
    Jwang B; Yerushalmi N; Kreitman RJ; Engberg J; Pastan I
    Immunotechnology; 1999 Mar; 4(3-4):231-6. PubMed ID: 10231092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction of human phage-displayed scFv library and selection of the ScFv against rabies virus].
    Zhao XL; Yin J; Wang H; Jiang M; Hou XJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):243-7. PubMed ID: 15191736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation.
    Pelat T; Hust M; Laffly E; Condemine F; Bottex C; Vidal D; Lefranc MP; Dübel S; Thullier P
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2758-64. PubMed ID: 17517846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant single-chain variable fragment antibodies directed against Clostridium difficile toxin B produced by use of an optimized phage display system.
    Deng XK; Nesbit LA; Morrow KJ
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):587-95. PubMed ID: 12853390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of antibody molecules through antibody engineering.
    Kipriyanov SM
    Methods Mol Biol; 2003; 207():3-25. PubMed ID: 12412465
    [No Abstract]   [Full Text] [Related]  

  • 12. Importance of the linker in expression of single-chain Fv antibody fragments: optimisation of peptide sequence using phage display technology.
    Turner DJ; Ritter MA; George AJ
    J Immunol Methods; 1997 Jun; 205(1):43-54. PubMed ID: 9236914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-step single-chain Fv recombinant antibody-based purification of gp96 for vaccine development.
    Arnold-Schild D; Kleist C; Welschof M; Opelz G; Rammensee HG; Schild H; Terness P
    Cancer Res; 2000 Aug; 60(15):4175-8. PubMed ID: 10945626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered antibodies.
    Hudson PJ; Souriau C
    Nat Med; 2003 Jan; 9(1):129-34. PubMed ID: 12514726
    [No Abstract]   [Full Text] [Related]  

  • 15. High-throughput generation and engineering of recombinant human antibodies.
    Krebs B; Rauchenberger R; Reiffert S; Rothe C; Tesar M; Thomassen E; Cao M; Dreier T; Fischer D; Höss A; Inge L; Knappik A; Marget M; Pack P; Meng XQ; Schier R; Söhlemann P; Winter J; Wölle J; Kretzschmar T
    J Immunol Methods; 2001 Aug; 254(1-2):67-84. PubMed ID: 11406154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity and folding properties both influence the selection of antibodies with the selectively infective phage (SIP) methodology.
    Pedrazzi G; Schwesinger F; Honegger A; Krebber C; Plückthun A
    FEBS Lett; 1997 Oct; 415(3):289-93. PubMed ID: 9357985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage-displayed recombinant single-chain antibody fragments with high affinity for cholesteryl ester transfer protein (CETP): cDNA cloning, characterization and CETP quantification.
    Ritsch A; Ebenbichler C; Naschberger E; Schgoer W; Stanzl U; Dietrich H; Heinrich PC; Saito K; Patsch JR
    Clin Chem Lab Med; 2004 Mar; 42(3):247-55. PubMed ID: 15080555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A large semi-synthetic single-chain Fv phage display library based on chicken immunoglobulin genes.
    van Wyngaardt W; Malatji T; Mashau C; Fehrsen J; Jordaan F; Miltiadou D; du Plessis DH
    BMC Biotechnol; 2004 Apr; 4():6. PubMed ID: 15059288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of recombinant guinea pig antibody fragments to the human GABAC receptor.
    Memic A; Volgina VV; Gussin HA; Pepperberg DR; Kay BK
    J Immunol Methods; 2011 May; 368(1-2):36-44. PubMed ID: 21362428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of antibody phage-display technology and its applications.
    Hoogenboom HR
    Methods Mol Biol; 2002; 178():1-37. PubMed ID: 11968478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.